TIME France

Man Left Brain Dead After French Drug Trial Dies

Five others were still in hospital

A man who was left brain dead after an experimental drug trial in France has died, according to reports.

The patient was one of six people being treated in hospitals after a drug trial for a pharmaceutical firm in France went wrong earlier this week, Agence France-Presse reports.

The six patients were in good health until taking the oral medication in Rennes, north-west France, French Health Minister Marisol Touraine said in a statement. A “serious accident” left one person brain dead and five others ill, Touraine said.

Ninety volunteers took the drug, which was manufactured by the Portuguese company Bial, according to the BBC. The trial, which has been suspended, was conducted by a private laboratory.

A source told the AFP that the drug was a painkiller containing an active ingredient found in cannabis plants, cannabinoids. However, the French health ministry denied the claim.

The other five remain in a stable condition, the BBC reports. Four have “neurological problems” and one has no symptoms but is still being monitored.

Your browser is out of date. Please update your browser at http://update.microsoft.com


Dear TIME Reader,

As a regular visitor to TIME.com, we are sure you enjoy all the great journalism created by our editors and reporters. Great journalism has great value, and it costs money to make it. One of the main ways we cover our costs is through advertising.

The use of software that blocks ads limits our ability to provide you with the journalism you enjoy. Consider turning your Ad Blocker off so that we can continue to provide the world class journalism you have become accustomed to.

The TIME Team